Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
199.50    -3.10 (-1.53%)
Bid:
199.40
Ask:
200.00
Spread: 0.60 (0.301%)
Market Cap: £1.30b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Q4 AuM Statement

10 Jul 2014 07:00

RNS Number : 9142L
Ashmore Group PLC
10 July 2014
 



Ashmore Group plc

+0700 10 July, 2014

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces today the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2014.

Assets under Management

Investment theme

Actual31 March 2014

(US$ billion)

Estimated30 June 2014

(US$ billion)

Movement

Q4 vs Q3(%)

External debt

14.1

14.0

-0.7

Local currency

15.9

17.3

+8.8

Corporate debt

7.1

8.2

+15.5

Blended debt

18.6

20.6

+10.8

Equities

5.5

6.1

+10.9

Alternatives

2.5

2.5

-

Multi-strategy

2.4

2.7

+12.5

Overlay / liquidity

4.0

3.6

-10.0

Total

70.1

75.0

+7.0

 

Assets under management increased during the quarter to US$75.0 billion through a combination of net inflows totalling US$1.6 billion and positive investment performance of US$3.3 billion.

Net inflows were delivered across a range of fixed income and equities themes. The flows reflect a broad mix of clients by type and domicile, and were balanced in respect of mandate size. There was good demand for blended debt, corporate debt and local currency assets, while multi-strategy experienced institutional demand which offset the expected outflows from Japanese retail funds. There were net outflows in the external debt and overlay/liquidity themes.

Consistent implementation of the Group's long-standing investment processes resulted in portfolios buying into opportunities presented by the numerous periods of market weakness over the past 12 months. This approach has delivered positive investment performance over the quarter with all themes contributing except alternatives and overlay/liquidity, which were flat. Investment returns were particularly strong in the blended debt, local currency, external debt and equities themes.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Improving sentiment and the consequent market recovery have benefited those investors who remained focused on the economic and political fundamentals in Emerging Markets and who took the opportunity to invest in mis-priced assets earlier in the year. Looking ahead, the prospects for investment returns are enhanced by the on-going development of the asset class. New countries being represented in indices broadens the diverse range of opportunities available and supports increasing allocations by dedicated investors."

For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.7106 at 30 June 2014, a 3% weakening of the US dollar since 31 December 2013 (1.6557). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the second half of the year was 1.6734 (H1 2013/14: 1.5868; FY2012/13: 1.5690).

Ashmore will announce its preliminary results in respect of the financial year to 30 June 2014 on 11 September 2014. There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs at Peterborough Court, 133 Fleet Street, London, EC4M 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI Consulting - PR to Ashmore Group plcAndrew Walton +44 (0)20 3727 1514Paul Marriott +44 (0)20 3727 1341

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSAFMUFLSEIW
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.